General Principles of Pharmacologic Therapy
Zahinoor Ismail, Robert Granger, Bruce G. Pollock
Abstract
Zahinoor Ismail, Robert Granger, Bruce G. Pollock
Abstract
This chapter addresses many of the components of clinical pharmacology. Included are pharmacokinetics (PK), pharmacodynamics (PD), pharmacogenomics, and the role of herbal supplements, drugs of abuse, aging, and comorbid medical illness. PD addresses the time course and intensity of drug effects on the body or what the drug does to the body. Variability in PD can exceed that of PK such that similar plasma concentrations can produce different pharmacologic effects in different patients. The chapter discusses the drug-receptor concept, dose-effect relationships, metabolism and its variability, and PD drug interactions. The role of kinetic–dynamic (KD) modeling in clinical pharmacology is reviewed. PD differences are difficult to interpret without concentration data, hence combining PK and PD to address the relationship between concentration and effect is the purpose of KD modeling.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This chapter addresses many of the components of clinical pharmacology. Included are pharmacokinetics (PK), pharmacodynamics (PD), pharmacogenomics, and the role of herbal supplements, drugs of abuse, aging, and comorbid medical illness. PD addresses the time course and intensity of drug effects on the body or what the drug does to the body. Variability in PD can exceed that of PK such that similar plasma concentrations can produce different pharmacologic effects in different patients. The chapter discusses the drug-receptor concept, dose-effect relationships, metabolism and its variability, and PD drug interactions. The role of kinetic–dynamic (KD) modeling in clinical pharmacology is reviewed. PD differences are difficult to interpret without concentration data, hence combining PK and PD to address the relationship between concentration and effect is the purpose of KD modeling.
Key concepts: Pharmacogenomics, Pharmacodynamics, Pharmacokinetics, Pharmacology, Clinical pharmacology, Drug, Medicine, Plasma concentration